Clinical trial
Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or…
NCT00030706 · Montefiore Medical Center, Other · Completed
Key facts
| NCT number | NCT00030706 |
|---|---|
| Title | Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer |
| Official title | Phase II Study Of Epothilone B Analogue BMS-247550 In Relapse And/Or Refractory Stage III Or IV Ovarian Epithelial Cancer, Following Front-Line Treatment With Platinum Plus Taxane-Based Chemotherapy |
| Lead sponsor | Montefiore Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer, Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | ixabepilone |
| Start date | Nov 1, 2004 |
| Primary completion | Feb 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 28, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: